The fight against autoimmune diseases is gaining a powerful ally: Kinase Inhibitor in Autoimmune Diseases Market is projected to experience significant growth, with a revenue of USD 80,252 million anticipated by 2033. This impressive figure marks a substantial jump from the predicted USD 47,430 million in 2023, reflecting a robust compound annual growth rate (CAGR) …